T2 Biosystems Q2 2024 GAAP EPS $(0.66) Beats $(0.97) Estimate, Sales $1.952M Miss $2.100M Estimate
Portfolio Pulse from Benzinga Newsdesk
T2 Biosystems (NASDAQ:TTOO) reported a Q2 2024 GAAP EPS of $(0.66), beating the analyst estimate of $(0.97) by 31.96%. However, the company missed its sales estimate, reporting $1.952 million against the expected $2.100 million, a 7.05% shortfall and a 0.61% decrease from the same period last year.
July 29, 2024 | 8:22 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
T2 Biosystems reported a better-than-expected EPS of $(0.66) for Q2 2024, beating estimates by 31.96%. However, sales missed expectations by 7.05%, coming in at $1.952 million. This mixed result may lead to short-term volatility in the stock price.
The better-than-expected EPS is a positive sign, but the sales miss and slight year-over-year decline could create mixed sentiment among investors, leading to short-term volatility in TTOO's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100